DEXCOM INC is 2.6x more valuable than GLOBUS MEDICAL INC by market capitalization ($28.85 B vs $10.98 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GMED | DXCM |
|---|---|---|
| Market cap | $10.98 B | $28.85 B |
| US-listed rank | #892 | #473 |
| Revenue (latest FY) | $2.94B | $4.66B |
| Net income (latest FY) | $537.87M | $836.30M |
| Net margin | 18.3% | 17.9% |
| P/E (trailing FY) | 20.4 | 34.5 |
| SEC filings | 752 | 2,566 |
DEXCOM INC is 2.6x more valuable than GLOBUS MEDICAL INC by market capitalization ($28.85 B vs $10.98 B).
In their latest fiscal years, GLOBUS MEDICAL INC reported $2.94B in revenue while DEXCOM INC reported $4.66B.
Full pages: GLOBUS MEDICAL INC and DEXCOM INC, or browse the full rankings.